Menu Back toEnsuring Patient Engagement Methodologies Are ‘Fit for Purpose’ from the Beginning: A Key Factor for Meaningful Outcomes

DIA 2021 Global Annual Meeting

Ensuring Patient Engagement Methodologies Are ‘Fit for Purpose’ from the Beginning: A Key Factor for Meaningful Outcomes

Session Chair(s)

Nathalie Bere, MPH

Nathalie Bere, MPH

  • Patient Engagement
  • European Medicines Agency, Netherlands
Patient data helps ensure more patient-relevant regulatory outcomes. Patients are integrated within EMA and FDA’s regulatory procedures with demonstrated value. Relevant, robust and adaptable methodologies are vital to meet the changing health landscape.
Learning Objective : Discuss patient engagement methodologies within regulatory procedures; Identify value of patient input with tangible evidence; Describe the need for continuous, and adaptable, leveraging of the patient perspective for a better balance between scientific objectives and patient goals and ultimately reach more patient-relevant regulatory outcomes.

Speaker(s)

Marco Greco, PhD

Panelist

Marco Greco, PhD

  • President
  • European Patients' Forum, Belgium
Bruno Sepodes, PharmD, PhD, MPH, MSc

Panelist

Bruno Sepodes, PharmD, PhD, MPH, MSc

  • Vice-Chair-CHMP; Senior Nonclinical Expert INFARMED
  • INFARMED, Portugal
Andrea Furia-Helms, MPH

Panelist

Andrea Furia-Helms, MPH

  • Director of Patient Affairs, Office of Clinical Policy and Programs
  • FDA, United States